ARTL US Equity

Artelo Biosciences, Inc.

Nasdaq+ Compare Tear sheet →

Health Care · Pharmaceutical Preparations · CIK 1621221 · FY ends Dec 31

$0.69

-0.02 (-2.86%)

USD · as of 2026-08-21 · marketstack

Switch Ticker

8-K & ownership events Filings index (FLNG)

Documents (DOC)Legal & controls (LGCT)

Documents

6 of 6 10-Ks readable here

Period end	Filed	Form	Read here	EDGAR
2025-12-31	2026-02-24	10-K	read · risk factors · MD&A	index · original · 0001640334-26-000368
2024-12-31	2025-03-03	10-K	read · risk factors · MD&A	index · original · 0001640334-25-000335
2023-12-31	2024-03-25	10-K	read · risk factors · MD&A	index · original · 0001640334-24-000473
2022-12-31	2023-03-31	10-K	read · risk factors · MD&A	index · original · 0001640334-23-000509
2021-08-31	2021-11-29	10-K	read · risk factors · MD&A	index · original · 0001640334-21-002983
2020-08-31	2020-11-04	10-K	read · risk factors · MD&A	index · original · 0001640334-20-002722

▾Risk registerwhich risk-factor headings appeared in which year

63 captions · 6 filings

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

63 captions across 6 filings7 added10 dropped46 in every year6 of 6 10-Ks on file are cached here

2020	2021	2022	2023	2024	2025	Years
·	·	·	·	·	●	1
·	·	·	·	●	●	2
·	·	·	·	●	●	2
·	·	·	●	●	●	3
·	·	·	●	●	●	3
·	●	●	●	●	●	5 rw
·	●	●	●	●	●	5 rw
·	●	·	·	·	·	1
●	●	●	●	●	·	5
●	●	●	·	·	·	3 rw
●	●	●	●	●	·	5 rw
●	●	·	·	·	·	2
●	●	●	·	·	·	3 rw
●	●	●	●	●	·	5 rw
●	·	·	·	·	·	1
●	●	●	·	·	·	3
●	·	·	·	·	·	1
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6 rw
●	●	●	●	●	●	6
●	●	●	●	●	●	6

Risk-factor caption

2020

2021

2022

2023

2024

2025

Years

●

5 rw

●

5 rw

●

3 rw

●

5 rw

●

3 rw

●

5 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

6 rw

●

The filer's own 10-K text · 6 filings read

Rows are the filing's own headings, verbatim — nothing is summarized or generated.

A blank cell means the filer did not print that heading that year — not that the risk ended.

Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.

▾Filing languagedocument length, negation and hedging — chart it against price on GRAPH

6 filings measured

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

Filed	Period end	Document words	Item 1A words	Negation / 10k	Hedging / 10k	Filing
2020-11-04	2020-08-31	39,746	16,230	76.23	168.57	read · EDGAR ↗
2021-11-29	2021-08-31	40,334	17,251	73.14	173.55	read · EDGAR ↗
2023-03-31	2022-12-31	42,182	17,399	73.02	166.42	read · EDGAR ↗
2024-03-25	2023-12-31	52,920	19,796	68.59	169.31	read · EDGAR ↗
2025-03-03	2024-12-31	53,065	20,375	70.29	169.79	read · EDGAR ↗
2026-02-24	2025-12-31	57,990	20,077	65.7	162.44	read · EDGAR ↗

plot against the price on GRAPH: Document length · Item 1A length · Negation per 10k words · Hedging per 10k words

The filer's own 10-K text · 6 filings measured

House wordlists, not a licensed dictionary and not tuned against returns.

9 negation words · 40 hedging words — hover to read both lists.

Each point sits at its filing date and is held flat until the next filing.

ARTL US Equity☆

Documents

▾Risk registerwhich risk-factor headings appeared in which year

▾Filing languagedocument length, negation and hedging — chart it against price on GRAPH

ARTL US Equity